Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, July 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 5 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page
reddit: 1 Redditor

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Facebook Wikipedia Reddit Dimensions citations

So far, Altmetric has seen 1 public wall post.

Reaction Biology, 14 Jul 2017

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy: http://ow.ly/ZcDi30dreAb #kinase…